Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance

INTRODUCTION: 2018 World Health Organization (WHO) guidelines for the treatment of isoniazid (H)-resistant (Hr) tuberculosis recommend a four-drug regimen: rifampicin (R), ethambutol (E), pyrazinamide (Z) and levofloxacin (Lfx), with or without H ([H]RZE-Lfx). This is used once Hr is known, such tha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Respir J
Main Authors: Stagg, Helen R., Bothamley, Graham H., Davidson, Jennifer A., Kunst, Heinke, Lalor, Maeve K., Lipman, Marc C., Loutet, Miranda G., Lozewicz, Stefan, Mohiyuddin, Tehreem, Abbara, Aula, Alexander, Eliza, Booth, Helen, Creer, Dean D., Harris, Ross J., Kon, Onn Min, Loebinger, Michael R., McHugh, Timothy D., Milburn, Heather J., Palchaudhuri, Paramita, Phillips, Patrick P.J., Schmok, Erik, Taylor, Lucy, Abubakar, Ibrahim
Formato: Artigo
Idioma:Inglês
Publicado em: European Respiratory Society 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6785706/
https://ncbi.nlm.nih.gov/pubmed/31371444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.00982-2019
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados